Details
Title
Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
Author
Hultcrantz, Malin 1
; Hassoun, Hani 1
; Korde, Neha 1
; MacLachlan, Kylee 1
; Mailankody, Sham 1
; Patel, Dhwani 1 ; Shah, Urvi A. 1
; Tan, Carlyn Rose 1
; Chung, David J. 2
; Lahoud, Oscar B. 2
; Landau, Heather J. 2
; Scordo, Michael 2 ; Shah, Gunjan L. 2
; Giralt, Sergio A. 2
; Pianko, Matthew J. 3 ; Burge, Miranda 1 ; Barnett, Kelly 1 ; Salcedo, Meghan 1 ; Caple, Julia 1 ; Tran, Linh 1 ; Blaslov, Jenna 1 ; Shekarkhand, Tala 1 ; Hamid, Selena 1 ; Nemirovsky, David 4 ; Derkach, Andriy 4
; Arisa, Oluwatobi 5 ; Peer, Cody J. 5 ; Figg, William D. 5
; Usmani, Saad Z. 1
; Landgren, Ola 6
; Lesokhin, Alexander M. 1
1 Memorial Sloan Kettering Cancer Center, Myeloma Service, Department of Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
2 Memorial Sloan Kettering Cancer Center, Adult Bone Marrow Transplant Service, Department of Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
3 University of Michigan Medical School, Division of Hematology/Oncology, Department of Internal Medicine, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
4 Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
5 National Institutes of Health, Clinical Pharmacology Program, National Cancer Institute, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
6 University of Miami, Myeloma Division, Sylvester Comprehensive Cancer Center, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606)
; Hassoun, Hani 1
; Korde, Neha 1
; MacLachlan, Kylee 1
; Mailankody, Sham 1
; Patel, Dhwani 1 ; Shah, Urvi A. 1
; Tan, Carlyn Rose 1
; Chung, David J. 2
; Lahoud, Oscar B. 2
; Landau, Heather J. 2
; Scordo, Michael 2 ; Shah, Gunjan L. 2
; Giralt, Sergio A. 2
; Pianko, Matthew J. 3 ; Burge, Miranda 1 ; Barnett, Kelly 1 ; Salcedo, Meghan 1 ; Caple, Julia 1 ; Tran, Linh 1 ; Blaslov, Jenna 1 ; Shekarkhand, Tala 1 ; Hamid, Selena 1 ; Nemirovsky, David 4 ; Derkach, Andriy 4
; Arisa, Oluwatobi 5 ; Peer, Cody J. 5 ; Figg, William D. 5
; Usmani, Saad Z. 1
; Landgren, Ola 6
; Lesokhin, Alexander M. 1
1 Memorial Sloan Kettering Cancer Center, Myeloma Service, Department of Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
2 Memorial Sloan Kettering Cancer Center, Adult Bone Marrow Transplant Service, Department of Medicine, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
3 University of Michigan Medical School, Division of Hematology/Oncology, Department of Internal Medicine, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
4 Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952)
5 National Institutes of Health, Clinical Pharmacology Program, National Cancer Institute, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
6 University of Miami, Myeloma Division, Sylvester Comprehensive Cancer Center, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606)
Pages
164
Publication year
2024
Publication date
Dec 2024
e-ISSN
20445385
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3106863334
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.